GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Price-to-Funds-From-Operations

BioArctic AB (OSTO:BIOA B) Price-to-Funds-From-Operations : (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


BioArctic AB (OSTO:BIOA B) Business Description

Industry
Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.